Study on anti-osteosarcoma activity of ethanol extract of Venenum bufonis in vitro
- PMID: 24653556
- PMCID: PMC3957244
Study on anti-osteosarcoma activity of ethanol extract of Venenum bufonis in vitro
Abstract
Background: Venenum bufonis is the dried white secretion of the auricular and skin glands of Bufo gargarizans Cantor, or Bufo melanostictus Schneider, Bufonidae. It is used in the treatment of deep-rooted carbuncle, boils and swelling; pain in the throat, heart stroke, coma, abdominal pain, vomiting and diarrhea. The objective of this paper is to preliminarily observe the effects of ethanol extract of Venenum bufonis on growth, and proliferation of human osteosarcoma U2OS cell lines, and to provide a theoretical basis for an in-depth study of the clinical application of Venenum bufonis for osteosarcoma inhibition, with its mechanism of action.
Materials and methods: SRB assay was used to determine the effect of Venenum bufonis ethanol extract on U2OS cell line activity, and to detect its inhibitory dose-effect on osteosarcoma cells. FCM was applied to determine the effect of Venenum bufonis ethanol extract on U2OS cell apoptosis and to perform cell cycle analysis.
Results: As results, different Venenum bufonis ethanol extracts showed apparent concentration-effect relationships on U2OS cell lines. FCM analysis showed that it had a U2OS apoptosis promoting effect, which increased with increasing concentration. Cell cycle analysis revealed that the Venenum bufonis ethanol extract mainly arrested U2OS in the G0/G1 phase, preventing the cells from progressing to the S phase.
Conclusion: The study concluded that Venenum bufonis ethanol extract has an inhibitory effect on proliferation of osteosarcoma U2OS cells.
Keywords: U2OS; Venenum bufonis; antitumor.
Figures
Similar articles
-
[Effect of origin species, body weight, and gender on quality of Bufonis Venenum].Zhongguo Zhong Yao Za Zhi. 2022 Nov;47(22):6034-6041. doi: 10.19540/j.cnki.cjcmm.20220715.101. Zhongguo Zhong Yao Za Zhi. 2022. PMID: 36471927 Chinese.
-
[Research progress in quality control of Bufonis Venenum in preparations].Zhongguo Zhong Yao Za Zhi. 2023 Sep;48(17):4552-4568. doi: 10.19540/j.cnki.cjcmm.20230714.301. Zhongguo Zhong Yao Za Zhi. 2023. PMID: 37802796 Chinese.
-
[Processing evolution,chemical components and pharmacological effects of Bufonis Venenum].Zhongguo Zhong Yao Za Zhi. 2021 Jul;46(14):3529-3539. doi: 10.19540/j.cnki.cjcmm.20210409.601. Zhongguo Zhong Yao Za Zhi. 2021. PMID: 34402275 Review. Chinese.
-
[Research on therapeutic effects of bufonis venenum on L7212 leukemia and its mechanism].Zhong Yao Cai. 2014 Feb;37(2):199-201. Zhong Yao Cai. 2014. PMID: 25095334 Chinese.
-
Venenum bufonis: An overview of its traditional use, natural product chemistry, pharmacology, pharmacokinetics and toxicology.J Ethnopharmacol. 2019 Jun 12;237:215-235. doi: 10.1016/j.jep.2019.03.042. Epub 2019 Mar 21. J Ethnopharmacol. 2019. PMID: 30905791 Review.
Cited by
-
Study of Intravenous Single-Dose Toxicity Test of Bufonis venonum Pharmacopuncture in Sprague-Dawley Rats.J Pharmacopuncture. 2016 Jun;19(2):155-62. doi: 10.3831/KPI.2016.19.017. J Pharmacopuncture. 2016. PMID: 27386149 Free PMC article.
-
Bufalin-loaded bovine serum albumin nanoparticles demonstrated improved anti-tumor activity against hepatocellular carcinoma: preparation, characterization, pharmacokinetics and tissue distribution.Oncotarget. 2017 Jun 28;8(38):63311-63323. doi: 10.18632/oncotarget.18800. eCollection 2017 Sep 8. Oncotarget. 2017. PMID: 28968991 Free PMC article.
References
-
- Bielack SS, Kempf-Bielack B, Delling G, Exner GU, Flege S, Helmke K, Kotz R, Salzer-Kuntschik M, Werner M, Winkelmann W, Zoubek A, Jürgens H, Winkler K. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: An analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. Journal of Clinical Oncology. 2002;20(3):776–790. - PubMed
-
- Dong WB, Wu BL, Zhu MH. Clinical efficacy and functional characteristics of toad venom preparation. Chinese Medical & Pharmaceutical Journal. 2003;2(10):26–27.
-
- Haselsberger K, Peterson DC, Thomas DGT, Darling JL. Assay of anticancer drugs in tissue culture: comparison of a tetrazolium-based assay and a protein binding dye assay in short-term cultures derived from human malignant glioma. Anticancer Drug. 1996;7(3):331–338. - PubMed
-
- Kandioler D, Kromer E, Tuchler H, End A, Müller MR, Wolner E, Eckersberger F. Long-term results after repeated surgical removal of pulmonary metastases. Annual Thoracic Surgery. 1998;65(4):909–912. - PubMed
-
- Marina N, Gebhardt M, Teot L, Gorlick R. Biology and therapeutic advances for pediatric osteosarcoma. Oncologist. 2004;9(4):422–441. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials